In order to directly compare our method with the PrognoScan method, we ran the PrognoScan analysis on its website (www.abren.net/PrognoScan/) for genes from the RAS pathway such as NRAS, KRAS, and MAP2K1genes for Lung adenocarcinoma (LUAD) data. The gene discussed is KRAS; the disease is lung adenocarcinoma.